National Institute of Allergy and Infectious Diseases

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap

Tiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M

Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem